BRANT WANG to Ovarian Neoplasms
This is a "connection" page, showing publications BRANT WANG has written about Ovarian Neoplasms.
Connection Strength
1.468
-
Cytohistopathologic correlation of ovarian mesonephric-like carcinoma and female adnexal tumor of probable Wolffian origin. Diagn Cytopathol. 2021 Jun; 49(6):E207-E213.
Score: 0.510
-
Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Gynecol Oncol. 2007 Jul; 106(1):201-6.
Score: 0.199
-
Aneuploidy Landscape in Precursors of Ovarian Cancer. Clin Cancer Res. 2024 02 01; 30(3):600-615.
Score: 0.159
-
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions. Am J Surg Pathol. 2024 Apr 01; 48(4):475-486.
Score: 0.159
-
Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis. Cancer Res. 2022 12 16; 82(24):4528-4541.
Score: 0.147
-
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions. J Pathol. 2019 05; 248(1):41-50.
Score: 0.113
-
Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II. Gynecol Oncol. 2010 Nov; 119(2):250-4.
Score: 0.062
-
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res. 2004 Oct 01; 10(19):6432-6.
Score: 0.042
-
Molecular genetic analysis of ovarian serous cystadenomas. Lab Invest. 2004 Jun; 84(6):778-84.
Score: 0.041
-
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003 Mar 19; 95(6):484-6.
Score: 0.037